Compare Lupin Ltd with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs FULFORD INDIA - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN FULFORD INDIA LUPIN/
FULFORD INDIA
 
P/E (TTM) x 48.7 398.8 12.2% View Chart
P/BV x 2.5 6.2 40.1% View Chart
Dividend Yield % 0.0 0.1 -  

Financials

 LUPIN   FULFORD INDIA
EQUITY SHARE DATA
    LUPIN
Mar-19
FULFORD INDIA
Mar-14
LUPIN/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs986942 104.7%   
Low Rs720450 160.1%   
Sales per share (Unadj.) Rs369.5691.4 53.4%  
Earnings per share (Unadj.) Rs13.411.5 117.0%  
Cash flow per share (Unadj.) Rs37.415.4 243.4%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.3 0.0%  
Book value per share (Unadj.) Rs303.7380.0 79.9%  
Shares outstanding (eoy) m452.493.90 11,602.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.31.0 229.4%   
Avg P/E ratio x63.660.7 104.8%  
P/CF ratio (eoy) x22.845.3 50.4%  
Price / Book Value ratio x2.81.8 153.4%  
Dividend payout %017.4 0.0%   
Avg Mkt Cap Rs m386,0642,714 14,222.8%   
No. of employees `00017.70.4 3,982.9%   
Total wages/salary Rs m31,513505 6,240.2%   
Avg. sales/employee Rs Th9,453.86,073.0 155.7%   
Avg. wages/employee Rs Th1,782.01,137.4 156.7%   
Avg. net profit/employee Rs Th343.0100.7 340.7%   
INCOME DATA
Net Sales Rs m167,1822,696 6,200.2%  
Other income Rs m3,640125 2,902.9%   
Total revenues Rs m170,8222,822 6,053.7%   
Gross profit Rs m28,822-46 -62,116.8%  
Depreciation Rs m10,85015 71,382.2%   
Interest Rs m3,07810 32,403.2%   
Profit before tax Rs m18,53454 34,132.6%   
Minority Interest Rs m-890-   
Prior Period Items Rs m380-   
Extraordinary Inc (Exp) Rs m-3,4000-   
Tax Rs m9,01710 93,926.0%   
Profit after tax Rs m6,06645 13,569.4%  
Gross profit margin %17.2-1.7 -1,001.9%  
Effective tax rate %48.717.7 275.2%   
Net profit margin %3.61.7 218.9%  
BALANCE SHEET DATA
Current assets Rs m138,5361,738 7,969.6%   
Current liabilities Rs m61,299545 11,253.7%   
Net working cap to sales %46.244.3 104.4%  
Current ratio x2.33.2 70.8%  
Inventory Days Days8448 172.9%  
Debtors Days Days1124 2,611.9%  
Net fixed assets Rs m127,51612 1,071,563.0%   
Share capital Rs m90539 2,320.5%   
"Free" reserves Rs m136,5171,443 9,460.7%   
Net worth Rs m137,4221,482 9,272.8%   
Long term debt Rs m66,4170-   
Total assets Rs m279,4942,077 13,458.5%  
Interest coverage x7.06.7 104.5%   
Debt to equity ratio x0.50-  
Sales to assets ratio x0.61.3 46.1%   
Return on assets %3.32.6 125.4%  
Return on equity %4.43.0 146.3%  
Return on capital %8.94.3 207.0%  
Exports to sales %00-   
Imports to sales %024.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA659 0.0%   
Fx inflow Rs m59,41417 345,427.9%   
Fx outflow Rs m22,282673 3,310.1%   
Net fx Rs m37,132-656 -5,660.7%   
CASH FLOW
From Operations Rs m16,66090 18,510.8%  
From Investments Rs m-32,825105 -31,381.2%  
From Financial Activity Rs m7,441-14 -52,775.2%  
Net Cashflow Rs m-8,724181 -4,833.1%  

Share Holding

Indian Promoters % 46.6 0.0 -  
Foreign collaborators % 0.2 75.0 0.3%  
Indian inst/Mut Fund % 11.3 3.8 297.4%  
FIIs % 31.9 0.1 31,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 21.2 47.6%  
Shareholders   98,259 4,783 2,054.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   PFIZER  ABBOTT INDIA  PLETHICO PHARMA  WYETH LTD  GSK PHARMA  

Compare LUPIN With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slips Over 300 Points; Axis Bank & Tech Mahindra Top Losers(12:30 pm)

Share markets in India have extended early losses and are presently trading deep in the red. Barring consumer durables sector, all sectoral indices are trading in red with stocks in the telecom sector.

Related Views on News

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Sep 17, 2019 01:43 PM

TRACK LUPIN

LUPIN - AUROBINDO PHARMA COMPARISON

COMPARE LUPIN WITH

MARKET STATS